Use of darunavir and enfuvirtide in a pregnant woman

Simple item page
dc.contributor.authorSued, Omar
dc.contributor.authorLattner, Julia
dc.contributor.authorGun, Ana
dc.contributor.authorPatterson, Patricia
dc.contributor.authorAbusamra, Lorena
dc.contributor.authorCesar, Carina
dc.contributor.authorFink, Valeria
dc.contributor.authorKrolewiecki, Alejandro J.
dc.contributor.authorCahn, Pedro
dc.date.accessioned2024-05-23T18:53:34Z
dc.date.available2024-05-23T18:53:34Z
dc.date.issued2009
dc.description.abstractA 41-year-old pregnant woman with multiple virological failures started darunavir, enfuvirtide, zidovudine and lamivudine at week 28 of pregnancy. During week 38, the patient had a viral load <400 copies/mL and a CD4 count of 180 cells/mm(3) (13%). The child was found to be in good health, with negative HIV-polymerase chain reactions at birth, at two and at six months.
dc.identifier.citationSued, O., Lattner, J., Gun, A., Patterson, P., Abusamra, L., Cesar Carina, Fink, V., Krolewiecki Alejandro J., & Cahn, P. (2008). Use of darunavir and enfuvirtide in a pregnant woman. International Journal of STD & AIDS.
dc.identifier.otherDOI: 10.1258/ijsa.2008.008075
dc.identifier.urihttps://repositorio.huesped.org.ar/handle/123456789/1116
dc.relation.ispartofseriesInternational Journal of STD ; AIDS
dc.subjectDarunavir
dc.subjectenfuvirtide
dc.subjectPregnant woman
dc.titleUse of darunavir and enfuvirtide in a pregnant woman

Files

Collections

Articulos científicos